NCT05015673View on ClinicalTrials.gov

This is a Study to Determine the Effect of Multiple Doses of an Investigational Drug, Taken by Mouth, in People With Narcolepsy-cataplexy. Accepting Both Males and Females Ages of 18 Years to 55 Years. This Study Will be Conducted in the US and Will Require Approximately 13 Weeks Participation.

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 5, 2014

Primary Completion Date

May 26, 2015

Study Completion Date

May 26, 2015

Conditions

Narcolepsy

Interventions

DRUG

SEP363856

DRUG

Placebo

Trial Locations (6)

27710

Duke University Medical Center, Durham

29201

SleepMed of South Carolina, Columbia

30342

NeuroTrials Research Inc., Atlanta

33707

Clinical Research Group of St. Petersburg, St. Petersburg

77063

Todd Swick, MD PA, Houston

92868

SDS Clinical Trials, Inc., Orange

All Listed Sponsors

lead

Otsuka Pharmaceutical Development & Commercialization, Inc.

INDUSTRY

NCT05015673 - This is a Study to Determine the Effect of Multiple Doses of an Investigational Drug, Taken by Mouth, in People With Narcolepsy-cataplexy. Accepting Both Males and Females Ages of 18 Years to 55 Years. This Study Will be Conducted in the US and Will Require Approximately 13 Weeks Participation. | Biotech Hunter | Biotech Hunter